by Robert Kimmel –
Greenburgh has opened the way for the town’s largest employer, Regeneron Pharmaceuticals, Inc., to structure a major expansion close to its headquarters in Tarrytown.
The Town Board found that a potential 1,000,000 square foot development by Loop Road Holdings, LLC, a subsidiary of Regeneron, would not have any significant negative environmental impacts, and last month approved the company’s site plan application. The 100 acre parcel where it intends to build is just south of its headquarters and is now vacant.
Lauding the proposed project, Town Supervisor Paul Feiner noted, “Regeneron has continued to grow rapidly and will now have the opportunity to consider creating a campus with nine buildings…of research and development and related spaces in the Town of Greenburgh as they evaluate their future expansion options.”
“The architectural renderings submitted in support of the plan are remarkable,” Feiner said. “The approved plan was designed to have a village-like feel and incorporates structured parking, plaza space, outdoor collaboration space, and integrated open space in environmentally sustainable buildings.”
Regeneron, whose headquarters is at 777 Old Saw Mill River Road in Tarrytown, gave no additional specifics regarding its expansion or potential employment growth locally; however, its Director of Corporate Communications, Alexandra Bowie, provided this statement: “Regeneron continues to expand as we advance our mission of bringing important new medicines to people with serious diseases. This recent site plan approval will provide us the flexibility to potentially expand our research and development campus in the future as needed. We appreciate the continued support of our communities, county and New York State in helping us plan for our ongoing growth.”
Feiner, described the company as, “an innovator in the life science industry,” and added, “The potential expansion will further cement the growth of this bio-tech cluster in the Town of Greenburgh, Westchester County and New York State, and builds upon the vision laid out by the Town Board in the Town of Greenburgh’s Comprehensive Plan.” Feiner commented, “The Town Board is proud to support the continued growth of Regeneron.”
Regeneron recently received recognition for its employment practices. Science magazine gave the company top status as the world’s “#1 Biopharma and Pharmaceutical Employer” for the fifth time. It is the seventh consecutive year that Regeneron has had the first or second top employer ranking in the magazine’s annual survey of the biotech and pharmaceutical industry. It stands as the magazine’s most highly ranked company over the past decade. Regeneron has more than 6,000 employees at its various locations.
The magazine stated, “Survey respondents rated Regeneron highly based on 23 characteristics, including financial strength, easy adaptation to change and a research-driven environment. Employees rated Regeneron highest when it came to having a clear vision for the future, being socially responsible and treating colleagues with respect.”
Regeneron was founded in 1988 by physician scientists, Leonard S. Schleifer, Alferd G. Gilman, and Eric M. Shooter. A recent announcement regarding its presentation at a healthcare conference noted that the company’s ability to “…translate science into medicine has led to six FDA-approved treatments and over a dozen product candidates in development, all of which were homegrown in our laboratories.”